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Abstract
Purpose: To assess the neuroprotective effect of CD 34+ stem cells on retinal ganglion cell (RGC) survival after optic
nerve compression injury (ONCI).
Methods: The optic nerve compression injury was obtained through exerting pressure on the optic nerve 1 mm behind
the eye globe for duration of 60 seconds. This compression was conducted using a stereotactic device attached to small
forceps after good exposure to optic nerve. Treatment of ONCI model was done through intravenous administration of
3,000,000 CD34+ stem cells intravenous through rat tail was done six hours after the onset of the nerve crush injury.
Evaluation of the effect of CD34 positive stem cells on injured retinal cells was obtained 6 days after ONCI through the
following: (1) immunohistochemistry through Brn-3b labelled RGCs and, (2) electrophysiological changes was studied
using F-VEPS after dark adaptation period.
Results: Brn-3b labeled RGCs density was found with an average of 1490 /70074 µm² in the normal retina of adult
female Wistar rat animal, in compared to 366 / 70074 µm² in the retina of non treated ONCI. Flash–Visual Evoked
potentials (f-VEPs) were prolonged from 50 msec in control rats to 110 msec in experimental rats after treatment with
stem cells, there was an increase in the number of RGCs with an average of 999 / 70074 μm² and reduction in the latency
of F. VEPs to 91 msec in the CD 34 + treated group.
Conclusion: Intravenous administration of 3,000,000 human umbilical cord blood CD 34+ stem cells may have a
potential neuroprotective effect on damage/injured retinal ganglion cells manifested by an increase in the survival of
retinal ganglion cells (56%)and an improvement in the latency period of f-VEPs in the optic nerve compression injury
model treated with stem cells (33%).
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Abbreviations: ONCI: Optic Nerve Compression
Injury; RGC: Retinal Ganglion Cell; IOP: Intraocular
Pressure; SCI: Spinal Cord Injury

Introduction
World Health Organization statistics indicates that
glaucoma accounts for blindness of at least 5 million
people, causing 13.5% world blindness. In unites States,
glaucoma is the second leading cause of blindness and the
second most frequent reason for ambulatory visits to
physician in US. In glaucoma, progressive death of Retinal
Ganglion Cells (RGCs) leads to optic nerve degeneration
and progressive loss of vision. The main lines of glaucoma
treatment focus on reduction of intraocular pressure
(IOP) either surgically or pharmacologically. There are
strong evidences that lowering IOP provides
neuroprotective effects on injured RGCs. Even with a
controlled IOP, there is a progressive loss of RGCs.
Consequently, there is an increase need for
neuroprotective agents that may preserver RGCs in the
presence of normal IOP in glaucoma patients.
The optic nerve compression injury (ONCI) has served
as an important model for studying the non-neuronal
response to an injury and for studying axon regeneration
in the CNS [1-4]. It is also a well-established model to
study glaucoma and RGCs. ONCI leads to death of RGCs as
a direct result of primary damage to the axons secondary
to the disruption of retrograde axonal transport [5].
Additional damage is caused by “secondary degeneration”
of RGCs that escaped direct injury, but are susceptible to
damage by different toxic mediators released into the
extracellular environment by dying RGCs.
We focused in this experiment on restoring injured
RGCs after ONCI through the use of Human umbilical cord
blood stem cells (hUCBCSs). hUCBCSs are one of the
strongest candidates used in cell therapy for spinal cord
injury (SCI) because of its greater availability, weak
immunogenicity, and lower risk of viral transmission [6].
The goal of this study is investigate the neuroprotective
effects of hUCBCSsCD34+on adult rat after optic nerve
compression injury. The neuroprotective effects of
hUCBCSsCD34+ were assessed based on survival of RGCs
and improvement in the latency time of F-VEPs.

Material and Methods
All experiments were performed in accordance with
the ARVO Statement for the Use of Animals in Ophthalmic
and Vision Research, and Animal Care and Use Committee

requirements. In this study, we used adult female Wistar
rat animals, as they have been known to be sensitive to
optic nerve trauma based on the level of Glutamate mRNA
[7,8]. In addition, Wistar rat animals have been used
extensively in experimental ophthalmology and visual
science for evaluation of different lines of treatment.
In this study, we aimed to evaluate the neuroprotective
effect of hUCBCSsCD34+oninjured RGCs after optic nerve
compression injury. We compared the neuroprotective
effect of hUCBCSsCD34+on three different groups of
animals:
(i) Group A, normal animals without any ONCI.
(ii) Group B, animals exposed to ONCI for one minute
without stem cell therapy.
(iii) Group C, animals who were exposed to ONCI for one
minute then treated for six hours after the onset of
compression injury with 3,000,000 hUCBCSsCD34+.
The
evaluation
was
conducted
using
immunohistochemistry to assess RGCs densities and the
functional analysis we used electrophysiological function,
f-VEPs, to measure the latency of flash visual evoked
potential.

Optic Nerve Compression Injury Device
Our group built a simple device to provide a uniform
amount of optic nerve damage. This optic nerve
compression injury device was composed of blunt forceps
attached and manipulated by a stereotaxic device
manipulator. This model provided a more uniform
amount of pressure on optic nerve rather than other
maneuvers. After good exposure of the optic nerve
through fine dissection of the surrounding tissues, the
forceps was applied for one minute directly between the
meanings and the optic nerve just one mm behind the eye
globe to avoid injury of the capillary network. The
micromanipulator was adjusted to enable the forceps to
crush the optic nerve without any change in the amount
of force-applied force exerted on the optic nerve [9]. This
model was used to simulate mechanical non-ischemic
trauma to the optic nerve.

Optic Nerve Compression Injury
Adult female Wistar rats were used with an average
weight of 200-250 gm and average age of 2 to 3 months.
The animals were anesthetized with 10 mg/Kg Xylazine
(Phoenix Pharmaceutical, St. Joseph, MO) and 80 mg
Ketamin (Pfizer Parke-Davis, Morris Plain, NJ).
Sterilization of the surgical field was done using Betadine.
Topical anesthetic drops were used to the cornea five
minutes before the surgery using 0.5% proparacaine
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(Alcaine, Ophthetic, Paracaine). The head was fixed in a
stereotaxic frame and the surgical procedure was
conducted through obtaining a good exposure of the optic
nerve with minimum soft tissue damage and without
injury to the surrounding blood vessels. We accessed the
orbit through an incision in the lateral angle of the eye, a
lateral canthatomy. The conjunctiva was dissected along
the temporal limbus from 1 to 4 o'clock.
The eye globe was rotated nasally using a fixating
suture (7-0 silk) through the conjunctiva and almost the
entire Harderian gland was removed. While dislocating
the eyeball anteriorly, the ocular muscles overlying the
optic nerve was separated and held apart. The optic nerve
was exposed by cutting the lateral rectus muscle and by
blunt dissection of the tissue surrounding the optic nerve.
Then with the aid of fine blunt scissors (used for
tenotomy, Westcott), the tissues behind the eyeball and
the extra ocular muscles around the optic nerve was
dissected: the whole meninges were finely dissected along
the optic nerve, while avoiding injury to the ophthalmic
blood vessels. At this point, we had a good exposed
portion of the optic nerve [10]. The meninges were cut
sparing the surrounding blood vessels to have a good
portion of the optic nerve. The compression injury was
conducted 1 mm behind the eye globe for 60 seconds
using the standard surgical forceps.
The skin and the conjunctiva were sutured using 4-0
silk and 7-0 nylon, respectively. Postoperative care
consisted of the following; (i) topical antibiotics: Ocuflox
(Of loxacine) 0.3% 1-2 drops, once or as needed: (ii)
topical anesthetics: proparacaine HCl 0.5% 1-2 drops,
once or as needed: (iii) Carboxyl Methylcellulose: refresh
celluvisc 1% once or as needed. We monitored the eye
daily after the surgery to assess any signs of infection or
rejection after hUCBCSsCD34 implantation such as
corneal opacity, redness or intraocular hemorrhage.

Immunohistochemistry
Brn-3b is a member of the POU-domain family of
transcription factors that plays a critical role in regulating
gene expression, particularly in cells of the nervous
system [11]. Brn-3b has been found to be expressed in a
sub-population of the RGCs nuclei of various species,
including mouse, chicken, rabbit, monkey and human
[12].

Brn-3b Stained Retinal Ganglion Cell Positive
Nuclei
Eyes were harvested from euthanized female Wistar
rat and were dissected from the cornea, iris and lens.

Eyecups were rinsed in saline before fixation. The whole
eyes were fixed for at least two hours in 4%
Paraformaldhyde in Dulbecco's phosphate buffered saline
(Invitrogen 14200-075, Grand Island, USA). Eyes were
transferred to tris buffered saline with Tween-20 (TBST)
(Dako Cytomation S3306, Carpentaria, CA, USA) and
dissected to obtain intact, flattened retina in a four-leaf
clover shape. Vitreous was disrupt ted and removed
manually by pinching and tearing vitreous using two pair
of fine forceps. The retina was immersed in TBST in a 24
well tissue culture plate (Costar, Corning, NY, USA) and
was washed with successive rinse/drain cycles of TBST to
remove the residual fixatives. Retina was permiabilized
by 30-45 minutes incubation in 0.3%Triton X-100(X-100PC Sigma) in TBS, and then was washed three times with
TBST to remove the detergent. Non specific binding of
antibodies to resident retinal proteins were blocked by
incubating the retina with 3% bovine serum albumin
(BSA) (A-7030 Sigma) plus 10% normal donkey serum
(017-000-121 Jackson Immuno- Research) in TBST for 30
minutes with gentle agitation. If amplification of the BRN3b signal was desired, the endogenous retinal biotin
(Bhattacharjee et al; Ruggiero and Sheffield) was also
blocked using Avidin Biotin Block Kit (Vector Burlington,
VT, USA) [11].
The retina was incubated overnight with goat antimouse Brn 3b (SC6026 Santa Cruz Bio-technology, Santa
Cruz, CA, USA) and 3% BSA-TBST (1:50) at 4C with
shaking balance, then wash was done using TBST for 15
minutes with gentle agitation in 24 wheels. Retina was
then incubated with 1:200 dilution of donkey-anti-goat
biotin (705-065-1470) for two hours with gentle
agitation. Again, another wash was done using TBST for
15 minutes with gentle agitation in 24 wheels.
Amplification was obtained using a streptovidien Alexa
594 (5-11227) molecular probe in TBST-3%BSA (1:400)
for 30 minutes with gentle agitation. All retinal tissue was
flattened on super frost plus microscope slide 12-550-15
(Fischer Scientific, Pittsburgh, PA). Then mounting was
done using an Anti Fade Kit (P-7481 Molecular Probs).
Cover slides were added on the retinal tissue. After the
slide dried, four areas circling the optic nerve from each
retina were digitally imaged. We used a DAS Microscope
LEICA DM IRB/E, which was mounted by SPOT RT color
camera. ADVANCED SPOT software was used for image
adjustment [13].

Image Capture and Analysis
The images were obtained using fluorescent
microscopy (DAS Microscope LEICA DM IRB/E, which was
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mounted by SPOT RT color camera. ADVANCED SPOT
software was used for image adjustment) by obtaining
four different images in four different quadrants with the
same distance from the optic disc to assure a uniform
density of RGCs. Capturing of these images were obtained
using 10X for better localization of the optic disc, then we
had four different images in four different quadrants with
an equal distance from the optic nerve to ensure the
homogenous RGCs density using 40X lens power.
Processing of these images were conducted using Spot
Advanced Medicine Software (SPOT Imaging Solutions, a
division of Diagnostic Instruments, Inc., 6540 Burroughs
Sterling Heights, MI 48314, USA).
The images analysis was conducted using NIH-Soft
image analysis J-1.33, which allowed us to analyze the
fluorescent particle with an average size of 20-60 m
square (2 to 6 pixels). The analyses of these images were
done using the fast red fluorescent mode. This was started
with subtraction of the background with enhancing of the
contrast, which was followed by adjusting the threshold.
Finally, the particles analysis was obtained with an
average size of 2 to 6 pixels. The chosen four quadrants
surface area is 700074 um² in comparison to the surface
area of the whole retina of rat, which is 3.8 mm².

Flash Visual Evoked Potential (f-VEPs)
F-VEP is a reliable method for testing the integrity of
the visual pathway from the retina to cortex. The rats
were deeply anesthetized with sodium pentobarbital (50
mg/Kg) and placed into a stereotactic head frame device.
Two holes were drilled through the skull of each animal,
enabling two stainless steel frame screws to be placed in
contact with the cortex serving as electrodes. The dura
was kept intact to minimize the cortical damage. The
“reference" and" active" electrodes positions were 5 mm
anterior to the bregma, 1.5 mm left of the midline, and 8
mm caudal to the bregma and 3 mm right of the midline,
respectively.
F-VEP originates from the left eye, recorded in the right
visual cortex, and was evoked by light stimulation after
implantation of the electrodes. The xenon light source of a
Grass PS22C Photic Stimulator was centered over the left
eye at a distance of 10 cm, while the right eye was covered
with black plastic tape to avoid the possibility of a VEP
response originating from it. Single flash stimuli 10 m sec
in duration were delivered in darkened room at an interstimulus interval of approximately 10 sec with a peak
light intensity of 19 million lumens. The signal from the
reference and active electrode were differently amplified

at a again of 1000, filtered between 1 and 100 Hz, and
sampled digitally at 500 Hz.
F-VEPs measurements were recorded as a voltage
fluctuation during a single 1000-msec sweep, where the
beginning of each sweep coincided with triggering of light
stimulus. Minimum of 60 individual measurements were
collected and were presented as mean plus or minus
standard of deviation. F-VEPs were done 6 days after
optic nerve crush injury to the three groups of animals.
These animal groups included the followings: (i) normal
rats without crush injury, (ii) Sham control, non stem cells
treated ONCI rats; and (iii) hUCBCSsCD34+treated ONCI
rats.

Stem Cell Isolation
Endothelial Progenitor Cells: Fresh whole blood was
obtained from the human cord blood under an IRB
approved protocol. Blood was collected in heparinized
tubes. The blood was diluted 1:2 in phosphate buffered a
line (PBS) plus 2 mM EDTA (Ethylene diaminetetra acetic
acid), layered onto lymphocyte separation medium
(Ficoll, density 1.077 g/ml, ICN Biomedical, Aurora, OH)
and centrifuged for 30 minutes at 1,900 RPM, and at a
temperature of 20°C (35 ml blood was very gently added
onto 15 ml lymphocyte separation medium in every 50 ml
sterile tube). Then the white ring fraction (mononuclear
cell layer) was transferred to a new 50 ml tube using a
sterile Pasteur pipette, PBS was added two times and the
tubes were centrifuged for 15 minutes at 1500 RPM at
room temperature. After discarding the supernatant, the
pellet was resuspended in 4 ml ACKlysine buffer to get rid
of (for lysing) remaining erythrocytes. Mononuclear cells
(MNCs) were incubated in the ACK lysine buffer for no
more than 3 minutes on ice. After 3 minutes, 20 ml PBS
was added to the solution, the cells were washed twice
(centrifuge at 1200 RPM) with PBS.
Mononuclear cells (MNCs) were subjected to
immunomagnetic separation using an AC133 Cell
Isolation Kit (Miltenyi
Biotech; Auburn, CA;
http://www.miltenyibiotec.com), according to published
methods (45, 46). Briefly, MNCs were incubated for 45
minuteson ice with an FcR-blocking reagent (human IgG)
and AC 34MicroBeads. These micro beads are conjugated
with monoclonal mouse anti-human antibodies against
AC133. After washing with PBS plus 2 mM EDTA, the
labeled cells were filtered through a 20-µm nylon mesh
and loaded onto a column that was installed in a magnetic
field. Trapped cells were eluted after the column was
removed from the magnet. The collected cells were
named as AC 34+ endothelial progenitor cells.
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Results
Immunohistochemistry

Quantitative analysis of experimental animals was
done for 6 rats 6 days after ONCI, two in each group.
These rats showed no agitation or evidence of rejection
following hUCBCSsCD34+transplantation. All rats
survived the procedure including anesthesia, ONCI and
stem
cell
intravenous
administration
without
complications. Evaluation of the of the neuroprotective
effects of hUCBCSsCD34+stem cell on survival of RGCs
after optic nerve crush injury was studied by assessing
Brn-3b labeled RGCs density in four different quadrants
with the same distance from the optic nerve.
Brn-3b labeled RGCs density was 1490 /70074 µm in
normal retina (Figures 1-3). In the sham-surgery group,
Brn-3b labeled RGCs density was 366 /70074 µm (Figures
4-6), Brn-3b labeled RGCs density was 999 /70074 µm in
the retina of hUCBCSsCD34+treated ONCI model (Figures
7,8,9). The number of RGCs was obviously reduced in the
retina of the optic nerve crush injury model with an
average of 366 /70074 µm, with a reduction of almost
75% of RGCs of the normal retina. Brn-3b labeled RGCs
density was obviously increased after systemic
intravenous injection of 3,000,000 which was done 6
post-ONCI, with an average of 999 /70074 µm in the
treated group, with an increase in the survival of damaged
RGC at a mean count of 633 /70074 µm, saving more than
56% of damaged RGCs.

Figure 1: Normal RGCs distribution in animal 1.

Figure 2: Normal RGCs distribution in animal 2.

Figure 3: Normal RGCs distribution in animal 3.

Figure 4: Optic Nerve Compression Injury in animal 4.
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Figure 5: Optic Nerve Compression Injury in animal 5.

Figure 8: Optic Nerve Compression Injury treated with
stem Cells in animal 8.

Figure 6: Optic Nerve Compression Injury in animal 6.

Figure 9: Optic Nerve Compression Injury treated with
stem Cells in animal 9.

Flash -Visual Evoked Potentials

Figure 7: Optic Nerve Compression Injury treated with
stem Cells in animal 7.

Flash -Visual Evoked Potentials was done for 6 rats 6
days after ONCI, two in each group. Comparison of F-VEPs
latencies between non treated ONCI and the stem cells
treated ONCI group in comparison to normal rats without
ONCI:) and the latency period was 50 ± 0.9 msec (Figure
10) in normal rats. This result was compared to the the
latency period of non treated ONCI model which was 110
± 1.2 msec (Figure 11) and to the latency period of
hUCBCSsCD34+ treated ONCI, which was 90 ± 1.1 msec
(Figure 12). This revealed prolonged latency after ONCI,
which was partially shortened with hUCBCSsCD34+
transplantation.
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Discussion

Figure10: Flash
time=50msec.

VEP

on

normal

group.

Latency

Figure 11: Flash VEP on Optic Nerve Compression Injury
group. Latency time=110msec.

Figure 12: Flash VEP on Optic Nerve Compression Injury
group treated with Stem cells. Latency time=90msec.

We report for the first time that systemic intravenous
administration of hUCBCs CD34+ have a neuroprotective
effect on injured RGCs after ONCI: this effect was
demonstrated by increasing the survival of retinal
ganglion cells and improving the latency period of f-VEPs.
In this study, optic nerve compression injury was
accomplished using our previously described device (see
methodology): this compression was occurred for 60
seconds through applying the forceps on the optic nerve 1
mm behind the eye globe. This compression injury to the
axons of the neurons triggers degenerative responses.
These degenerative reactions proceed retrograde to the
soma and this is termed “Wallerian degeneration”.
After induction of ONCI, we injected 3,000,000
hUCBCSsCD34+intravenously six hours after the onset of
the crush injury. We performed Immunohistochemistry
and electrophysiological studies days after ONCI to assess
the neuroprotective effects. These neuroprotective effects
could be attributed to the migration of the stem cells to
the site of injury in response to chemotactic factors
release, in this case the optic nerve trauma. The
compression injury of the optic nerve leads to
complement activation at the site of injury and along the
distal portion of the nerve, as well as up regulation of the
complement inhibitor Cluster in astrocytes. Reactive
microglial cells seem to have a key role in complement
activation as a local source of C3. It has been suggested
that the balance between complement activation and
their regulators may have an impact on axonal
degeneration following opticnerve injury [14].
In this study , intravenous administration of 3,000,
000 hUCBSC CD34 + demonstrated neuroprotective
effects on the optic nerve crush injury model presented
with an increase in the survival of RGCs. Brn -3b labeled
RGCs density was 1490 / 70074 μm in the normal retina
in comparison to 366 / 70074 μm in the retina of non
treated ONCI model. There was a loss of an average 1124
/ 70074 μm. In the CD 34+ treated group, Brn-3b labeled
RGCs density was only reduced to 999 / 70074 in
comparison to the non-treated group where the average
of
RGCs
was
491
/
70074
μm.
Thus,
immunohistochemistry study provides credence to the
idea that CD34+ saved more than 505 / 70074 μm.
The average latency period of F-VEPs was 50 msec in
normal retina in comparison to non-treated optic nerve
compression injury at 110.6 msec. There was an
improvement in the latency period of f-VEPS in the optic
nerve compression injury model, which was treated with
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3,000,000 CD 34+ stem cells with an average latency
period of 91 msec, in comparison to the other ONCI nontreated group with an average latency period of 110.6
msec. As such, CD 34+ stem cell intravenous
administration improved the conductivity in the visual
pathway and presented with a shortening of the latency
period by 19.6 msec.
The improvement in RGC survival and in f-VEPs could
be attributed to neuroprotection rather than neurodifferentiation due to difficulty in stem cell penetration of
Bruch’s membrane. This study demonstrated the
neuroprotective effect of stem cells but did not reveal
their mechanisms. We will continue our work in this area
exploring the underlying mechanism of neuro
enhancement and neuroprotection. We will study the role
of different neurotrophic and growth factors in
neuroprotection.
Previous studies demonstrated the neuroprotective
effects of neurotrophins on the development and the
plasticity of the visual system of mammals and in
particular the visual cortex. In addition, NGF was found to
prevent all effects of monocular deprivation [15]. These
neurotrophins: NGF, BDNF, NT3, and N4 have a wide
range of effects in the development and the regeneration
of the neuronal circuit of the visual system.
This study has few pitfalls, such as the small number of
animals, absence of a positive control, and incomplete
analysis of f-VEPs and lack of study on neuroprotective
effect mechanisms through assessment of different
neurotrophic factors. We will address these shortcomings
in our future work.
This is a preliminary, but a promising experiment
where we explored the complicated physiology of the
neural circuit and how much hUCBCSsCD34+will have a
contributing role in the neuroprotection of RGCs in
compression optic neuropathy. Further work is required
to assess the progression of apoptosis and if the presence
of stem cell will delay or stop this process, progression of
apoptosis. This will include assessment of different
growth and neurotrophic factors levels such as BDNF,
NGF, NT3, NT4/5, CNTF, GDNF in addition to
neurotrophins’ surface receptors such as TrKA,
Tropomyosin related kinase family and the p75 receptors.
RGC die by apoptosis and this process were demonstrated
in models of optic nerve compression injury or axotomy,
experimental glaucoma and in human glaucoma. This
apoptotic process is triggered by various stimuli. It
involves intrinsic and extrinsic pathways which are the

major area of research to prevent or delay RGC death in
glaucoma (Molecular basis).

Summary
We
have
demonstrated
that
intravenous
administration of 3,000,000 hUCBCSsCD+ 34 stem cells
have a significant impact on preserving of injured RGCs
and retaining their electrophysiological functions. We
found that 3,000,000 hUCBCSs CD+ 34 intravenous
administrations preserve up to 63% of injured cells and
improve latency time by 33 %.

Conflicting Interest: There are no conflicts of interest
to disclose.
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